Tag Archives: Sexually transmitted disease

HIV positive patients fail to disclose their infection to NHS staff

trustinthenhs

A significant proportion of HIV positive patients may not be disclosing their infection to NHS staff, when turning up for treatment at sexual health clinics.

This is the finding suggested by preliminary research published online in the journal Sexually Transmitted Infections.

If the findings reflect a national trend, this could have implications for the true prevalence of undiagnosed HIV infection in the population, which is based on the numbers of “undiagnosed” patients at sexual health clinics, say the authors.

Currently, it is estimated that around one in four people in the UK who is HIV positive doesn’t know they’re infected with the virus.

The estimate is based on several sources of data, including the GUMAnon Survey, which routinely looks for HIV infection in blood samples taken from patients to test for syphilis at one of 16 participating sexual health clinics across the UK.

The results are then matched with the individual’s diagnostic status—whether they had been diagnosed before their arrival at the clinic, or were diagnosed at their clinic visit, or left the clinic “unaware” of their HIV status.

It is thought that a proportion of patients who do know their HIV status nevertheless choose not to reveal it to NHS staff when attending for services elsewhere.

To test this theory, the researchers analysed all HIV positive samples from one participating GUMAnon clinic in London in 2009 for the presence of very low viral loads— a hallmark of successful drug treatment—and various antiretroviral drugs.

Of the 130 samples which matched clinic records, 28 were from patients who were not known to be HIV positive before their arrival at clinic. Ten had been tested for HIV at their clinic visit.

The remaining 18 did not have a test at the clinic, and were therefore classified as undiagnosed. Yet almost three out of four (72%) of these samples had very low viral loads, indicative of successful drug treatment.

Only eight samples were of sufficient volume to be able to officially test for antiretroviral drugs, but evidence of HIV treatment was found in all of them.

“This is the first published objective evidence that non-disclosure of HIV status as a phenomenon exists in patients attending [sexual health] clinics in the UK,” write the authors.

“Given the high proportion of individuals classified within this study as [non-disclosing], the extent to which these findings can be extrapolated to other clinics, and the degree to which they may influence estimates of the proportion of undiagnosed HIV in the community, warrants further study,” they conclude.

The reasons why they don’t come clean(sic) about their HIV status may be that they don’t want to be “judged,” given that they have come to the clinic with another infection, which implies they are indulging in risky sexual behaviour, suggests lead author Dr Ann Sullivan of London’s Chelsea and Westminster Hospital NHS Foundation Trust.

But by not revealing their HIV status, they could be missing out on the chance to be treated more holistically and discuss other aspects of their health which might be affected by HIV, she says.

Original Article via Onmedica, taking medical information further.

DISCUSSION:

The comment by Ann (above) implies NHS staff are predisposed with attitudes toward sex.  Especially when using phrases like “when they don’t come clean” – However, NHS staff; particularly those within genitourinary medicine should not assume those who wish to have a HIV test participate in “risky sexual behaviour” as for a lot of people, HIV infection can simply occur when the HIV status of a sexual partner is positive, but not known and undiagnosed, then innocently passed to another (which is why is it recommended that condoms are used if the HIV status of the other person is unknown.

Do you have an opinion on this? – Let us know in the comments below.

READ MORE:

STAY UPDATED & JOIN THE CONVERSATION
Follow LASS on Twitter
or subscribe via email

Heather Alcock, policy advisor for the All Party Parliamentary Group on HIV & AIDS joins LASS.

Heather Alcock at the LASS AGM 6th October 2011

Heather Alcock presenting certificates to volunteers at the LASS AGM 6th October 2011

Heather Alcock, policy advisor for the All Party Parliamentary Group on HIV & AIDS has agreed to join the LASS Board of Trustees as a co-opted Trustee.

This is great news for us and will give us a good profile nationally as well as influence with local MPs.

The All-Party Parliamentary Group on HIV and AIDS is a backbench cross-Party group of MPs and Peers in the UK Parliament at Westminster.

MPs and Peers who have joined the Group have done so because they are concerned about both the devastation that HIV and AIDS are causing in developing countries and about their impact here in the UK including in our constituencies.

They believe that as parliamentarians they should play their part in addressing the HIV epidemic. In particular they say they have an important role in ensuring that laws and policies are respectful of human rights and promote public health.

On their website, you can read reports published by the Group, see examples of where we have raised issues about HIV and AIDS in Parliament and find out how to stay in touch with their work.

They say;

We value very highly the advice, guidance and support that we get from people living with HIV, NGOs and professionals outside Parliament. We hope that this website not only increases the information people can obtain about the Group, it also increases the dialogue between politicians and the people who are coping with the reality of life with HIV.

Please join us in welcoming Heather Alcock to our Board of Trustees.

STAY UPDATED
Follow LASS on Twitter
or subscribe via email
Related articles

Unsafe Sex in the City

Tonight, BBC3 will go behind the scenes of a sexual health clinic for a new four-part documentary, Unsafe Sex In The City.

The documentary explores the dangers faced by young people who have unprotected sex and follows the stories of patients whose passionate encounters have led to physical and emotional anguish.

The programme goes behind the scenes of a sexual health clinic in Manchester, with staff recounting traumatic stories as well as sharing humorous anecdotes about their efforts to protect youths from sexually transmitted infections.

The show isn’t typical family viewing, but parents of teenagers and sexually active people may want to consider it.  Tonight’s patients include 22-year-old Kervin, who forgot to “strap up” before a one-night stand; a pink-haired 17-year-old who doesn’t believe in monogamy or protection; and a smooth-talking womaniser who’s far less full of himself after being interrogated and prodded by a no-nonsense nurse.

A BBC spokesman added: “BBC3 are excited to have access to one of the country’s busiest sexual health clinics.”
The show airs tonight at 9pm on BBC3, repeated at 12:15am on Thursday morning (25th) – Then again on Saturday 27th at 3:05am – or view it on BBC iPlayer.
 
WE’LL BE WATCHING TONIGHT WITH TWITTER!
Follow LASS on Twitter
or subscribe via email
Related articles

TRADE Sexual Health – 160 People Tested at Leicester Pride 2012

Trade Sexual Health is a HIV & AIDS prevention charity based in Leicester for people living in Leicester, Leicestershire and Rutland.

They provide free and confidential advice and support to anyone who identifies as gay, lesbian, bisexual, men who has sex with men or women who has sex with women.

The city of Leicester has the fastest-rising HIV rate in the east Midlands and the sixth-highest in the country.

Leicester GU accompanied Trade on site providing HIV tests for the community alongside other activities.  LASS would like to say a big thank you, and congratulate Leicester GU with Trade for achieving 160 Kwik Prick, Rapid HIV Tests for the community.  Here’s an update on their day, from Trade:

Breaking Record! 160 People Tested at Leicester Pride 2012

Now at the forefront of sexual health, Trade Sexual Health joined forces once again with Leicester GUM Clinic to provide the Trade Health & Wellbeing Marquee at Leicester Pride 2012!

Our nationally recognised Trade GU clinic at Leicester Pride tested a record 160 people. All 160 had a full sexual health screening beating last year’s 136. With infection rates increasing, and undiagnosed HIV on the rise, this was a fantastic achievement, Thank you to the 160 people who tested.

Pride goers took part in fitness classes, had health checks, accessed information, booked in for a free massage and visited a host of other health and wellbeing stands in the Marquee. As usual Trade brought along a load of resources and goodies and we launched our new health campaign raising awareness of STIs. The willy sweets promoting this campaign seemed to attract a lot of attention.

We managed to give out roughly 3,000 free condoms to those present on the day.

Thank you to everyone who came along; to Leicester Pride, Leicester GU, sponsors, all the volunteers, staff and our committed Board of Trustees, for a fantastic day.
We are confident that we will build on this success and provide an even bigger and better Trade Marquee next year.

- Tradesexualhealth.com

If that wans’t enough Gay Pride for you, we were there too! – Click this to find out more.

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

HIV Awareness “Drops Off Radar”

Listen to this article instead:


It’s claimed infection rates are still high and many people don’t understand what it’s like living with the illness.

Figures from the Health Protection Agency (HPA) show there were nearly 6,000 confirmed cases in adults across the UK in 2011.

In the last five years nearly 3,500 16 to 24-year-olds have been diagnosed.

Paul Steinberg is a sexual health expert based in Lambeth, south London.

He said: “I think it’s a fair point to say awareness of HIV generally has dropped off the radar for a lot of people in this country.”

Paul believes the medical advances made in treating HIV over the past decade have led to people becoming more complacent and taking more risks.

He also says the increased focus on other, more common, STIs like chlamydia and gonorrhea means young people aren’t as educated as they should be on HIV.

“If someone is diagnosed with chlamydia then we can give them some antibiotics and they will be cured,” he said.

“Although HIV is not a death sentence any more, if someone does get diagnosed it’s a long-term, long-lasting condition.

“It’s not the same as having chlamydia or gonorrhea which can be treated.”

Infection myths

Sarah, which is not her real name, is 25 and was born with HIV.

She agrees there are too many young people who don’t know enough about the virus.

Sarah’s been doing work with the charity Body and Soul, which has launched a campaign called Life In My Shoes to challenge people’s misunderstandings of HIV.

The Department of Health recently announced £8m would be spent on raising awareness of HIV in England over the next three years.

The bulk of that money will be given to The Terrence Higgins Trust, one of the UK’s leading sexual health charities.

Genevieve Edwards from the Trust agreed more work needed to be done.

She said: “There’s a new generation who haven’t had basic training.

“The government is funding us to target our campaigns for those most at risk, which are gay and black and African communities.

“However, it’s true to say much more can be done for the population as a whole and generally young people.”

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Sex education: we should teach young people about more than the mechanics

Sex education: too much emphasis on the mechanics, says Doortje Braeken, who argues for more teaching about sexuality. Photograph: David Levene (The Guardian)

Sex education polarises opinion, sets legislators against parents and parents against schools and regularly inflames media opinion. Somewhere in the middle sit young people: ill-served, receiving confused messages and gaining their information from famously unreliable sources, such as peers or the internet.

Sex education, as all too many experience it, is like teaching people how to drive by telling them in detail what’s under the bonnet, how the bits work, how to maintain them safely to avoid accidents, what the controls do and when to go on the road. It’s all about the mechanics. And that’s it.

There’s a growing consensus that young people don’t need sex education, they need comprehensive sexuality education or CSE..  CSE is sex education plus: the mechanics, plus a lots more about sexuality.

That means not just teaching young people about the biology of sex, but also teaching them about the personal, emotional, societal and cultural forces which shape the way in which they choose to conduct their lives. Armed with this understanding, young people can make far more considered decisions.

This approach has the potential to unite the warring factions that bicker over the fundamental rights and wrongs of sex education: CSE equips young people with basic biological knowledge, but at the same time it equips them to question why they act in certain ways, and whether or not it is right, valuable or desirable to do so. CSE imparts information, and promotes responsibility.

CSE contains components which allow learners to explore and discuss gender, and the diverse spectrum of gender identities that exist within and between and beyond simple heterosexuality. It also contains components that examine the dynamics of power in relationships, and individual rights.

These are not taught as theoretical concepts. They have serious practical effects on the way in which young people interact with each other, both in the sexual and the wider social and educational spheres. Studies have shown that addressing such issues can have a marked impact both in school and the expansion of young people’s social networks.

CSE also engages with what some doubtless regard as difficult territory. Sexuality – however, individually, we choose to regard it – is a critical aspect of personal identity. The pleasure that we derive from sexuality, even if that pleasure is the pleasure of feeling that a reproductive duty is being fulfilled, is a vital part of our lives: it’s what makes us human. CSE views sexuality as a positive force.

CSE exploits a variety of teaching and learning techniques that are respectful of age, experience and cultural backgrounds, and which engage young people by enabling them to personalise the information they receive.

What is most telling is that a large number of studies have reached the clear conclusion that CSE does not lead to earlier sexual initiation or an increase in sexual activity. To paraphrase, traditional sex education seems to say: “If you’re going to do it, this is how everything works and you need to protect yourself in these ways to prevent this.” CSE says all that, but it also asks young people to ponder what exactly “it” is, and to deepen their perception of its implications.

In a political environment which is quantitatively driven, we measure the success of sex education in straightforward health behaviour indicators. These are easy to manage: numbers which build on existing health surveillance and measurement systems, and which are simple to understand from an objective point of view.

However, CSE is a far more nuanced discipline, and it will be necessary to include other measures of programme success: qualitative, subjective indicators which relate to gender equity, empowerment and critical thinking skills.

While governments have recognised young people’s right to CSE via various intergovernmental resolutions and conventions, the journey from recognition to delivery will be a long one. Even in the UK, there are notable differences, with England having a bare-bones biological approach “puberty, menstruation, contraception, abortion, safer sex, HIV/Aids and STIs should be covered”, while Wales and Scotland have curriculums which incline far more towards the CSE agenda.

The International Planned Parenthood Federation, the organisation I work for, and its 153 member associations around the world, has been instrumental in pressing for the adoption of international policy commitments to CSE. For many, it may seem like we are pushing 10 steps ahead of the agenda when the basic principle of young people’s right to even the most basic introduction to the biology of sex is still not universally accepted.

Our view is different: it is that CSE is what will secure widespread acceptance of sex education, because it is about more than the mechanics of sex. It is about helping young people, the world over, to become more healthy, more informed, more respectful and more active participants in the life of their community and their nation.

Doortje Braeken is the IPPF’s senior adviser on adolescents and young people, responsible for co-ordinating programmes in 26 countries implementing a rights-based approach to youth friendly services and comprehensive sexuality education. She will be among the panellists for a live discussion on sex and sexuality education, taking place on the SocietyGuardian site from noon to 2pm on Thursday 31 May

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Ambassadors on ‘HIV Heart to Heart’ campaign face death threats

English: The Red ribbon is a symbol for solida...

Reverend John Kwashie Azumah, Minister of the Gospel at Mount Zion Evangelical Ministries and member of ambassadors on HIV Heart to Heart campaign has said “the team had received threats on their lives since they went public with their HIV status”.

He said “those who attacked him included both Christians and non-Christians and they accused him of being a false prophet and a disgrace to the pastoral calling and therefore vowed to eliminate him, his wife and children”.

Rev Azumah who is also the National Chairperson of the International Network of Religious Leaders Living with or Personally Affected by HIV and AIDS, Ghana Chapter (INERELA+gh) disclosed this in an interview with the Ghana News Agency in Accra.

He said “although he was worried about the development, but was not afraid because he believed God was using him to tell a story to all those who were pretending to wake up to the reality that HIV and AIDS was no longer an issue of morality but a medical condition“.

Rev Azumah said “while it was globally accepted that HIV was no longer an issue of morality but a medical condition, many were yet to comprehend that the disease was no respecter of persons and its mode of transmission was diverse”.

He said “there was no need to cry over spilt milk, nor [lose valuable ideas], but to hold the bull by the horns and deal ruthlessly with the problem and help give hope to the many people living with the disease and further help eliminate stigma and discrimination”.

Rev Azumah said “stigmatising a person with HIV was in itself sin against God and encouraged all who were affected and infected with HIV and AIDS to strictly adhere to their medication and nutrition guidelines instead of substituting them for prayers from purported ‘Men of God’”.

He said “he was determined and committed in spite of the difficulties they faced from all angles including family, friends, communities to use the “Heart-to-Heart Media Campaign” to eliminate stigma and discrimination against people living with HIV and AIDS and achieves“zero discrimination” and ultimately a “zero infection””.

Rev Azumah appealed to the media, especially the electronic media to be circumspect in the their diction on issues relating to HIV and AIDS and give accurate reports devoid of all the unnecessary colouring that demean and further stigmatizes people living with the disease.

Mrs Mercy Acquah-Hayford, National Coordinator of INERELA+gh, appealed to religious bodies to offer positive messages that would give hope to persons living with HIV and not condemn them especially those who had boldly and openly declared their status and champion the fight against stigma and discrimination.

She said “some purported religious leaders often deceive unsuspecting and desperate people living with HIV to abandon their medications and substitute them for prayers and after they had deteriorated, were sent off to die away from their prayer camps”.

Mrs Acquah-Hayford advised people living with the disease to take their medications and support them with prayers for spiritual fulfilment and the possibility of total cure.

She appealed to Ghanaians to understand the fact that HIV was real and could affect anyone without caution, therefore the need to support those who had been bold to tell their story and encourage others to follow suit for treatment and care to help halt the spread of the virus and save a generation from the pandemic.

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

A Tale of Two Trials: How Adherence is Everything in PrEP

Adherence makes all the difference to the efficacy of pre-exposure prophylaxis (PrEP), the 19th Conference on Retroviruses and Opportunistic Infections (CROI) heard on Tuesday.

Further data were presented from two trials of PrEP (giving anti-HIV drugs to HIV-negative people to prevent infection), which announced dramatically different results last year.

In April 2011, the FEM-PrEP study found that giving HIV-negative women tenofovir/FTC (Truvada) pills to prevent their acquiring HIV was totally ineffective: there was no difference in HIV incidence between women taking Truvada and women taking placebo.

In July 2011, however, the Partners PrEP study found that Truvada was 73% effective in preventing HIV transmission between heterosexual partners of different HIV status.

How do we explain why giving HIV-negative women antiretroviral pills made no difference to the HIV infection rate in one trial, but prevented at least two in every three infections in the other? The difference, it appears, is that in the Partners PrEP trial, adherence to the study medication was very high, whereas in FEM-PrEP, despite counselling and support, less than half the women took their PrEP pills regularly.

The Partners PrEP study

The Partners PrEP study enrolled 4758 serodiscordant couples in Kenya and Uganda; the HIV-negative partner was female in 38% of couples. This study had three arms: a daily tenofovir pill, a daily Truvada pill, or placebo.

There were 17 infections in participants on tenofovir, 13 on Truvada and 52 on placebo. Efficacy overall was 75% in those assigned Truvada and 67% in those assigned tenofovir, though confidence intervals (44% to 81% in tenofovir and 55% to 87% for Truvada) overlapped, so the efficacy of the two regimens was the same statistically. The same was true of efficacy observed in women (65%) and men (70.5%).

Adherence according to pill counts of unused medication was 97%. A substudy (Donnell) compared tenofovir levels in the blood of 29 out of the 30 people who became infected in the two PrEP arms with levels in a random selection of 198 people who did not become infected.

Tenofovir was undetectable in the blood of 70% of the people who became infected but only 18% of the people who did not, indicating a ‘true’ adherence level of about 80% – and having a detectable level of tenofovir in the blood was associated with an 86% reduction in HIV risk in those taking tenofovir and a 90% reduction in those on Truvada.

The FEM-PrEP study

In the FEM-PrEP study, 2056 HIV-negative women in South Africa, Kenya and Tanzania were randomised to take a daily Truvada pill or a placebo. The trial was stopped when an interim analysis found near-identical HIV infection rates in both trial arms. There were 33 HIV infections in women taking Truvada and 35 in women taking placebo; this translates into annual incidence rates of 4.7% and 5.0% respectively. This 0.3% difference is no difference at all, statistically speaking (hazard ratio 0.94, 95% confidence interval 0.59 to 1.52, p = 0.81).

Participants in the study said they took their pills 95% of the time and adherence as measured by pill count was 85%. However when drug levels of tenofovir and FTC were measured in the blood of women assigned to Truvada, the investigators found that less than 50% of the women who should have been taking the drug had actually done so in the last 12 days, and less than 40% within the last 48 hours.

In infected participants, 26% had detectable levels of tenofovir in their blood in the last visit before they tested HIV positive, 21% at the visit they tested positive, and 15% at both visits; in non-infected participants whose samples were taken at the same visits they were 35%, 38% and 26% respectively.

Resistance

In FEM-PrEP, there were five cases of drug-resistant virus (all with the single M184V FTC resistance mutation), four in the Truvada arm and one on placebo. Two of the four cases in women assigned Truvada were clearly cases of transmission of virus that was already drug-resistant and not caused by women partially adherent to PrEP becoming infected, while the other two are still under investigation.

There were two cases of drug-resistant virus in Partners PrEP but in both cases these turned out to be people who were enrolled while suffering from acute HIV infection: there were no cases of drug-resistant virus amongst 74 infections post-randomisation.

One observation common to both studies was that the only side-effect that was measurably different between drug and placebo was nausea and vomiting. In Partners PrEP Truvada was associated with a modest increase in gastro-intestinal symptoms in the first month and in FEM-PrEP the rates were also significantly higher. Whether this is enough to deter participants from continuing their pills who are not strongly motivated needs further research.

Why were there differences in adherence?

Jared Baeten and Lut van Damme, principal investigators respectively of Partners PrEP and FEM-PrEP, were asked why they thought adherence was so much lower in FEM-PrEP than in Partners PrEP.

Baeten commented that they were very different populations. The men and women in Partners PrEP had to define themselves as being in a stable relationship – stable enough to last for at least the two-year length of the trial. Partners would have encouraged their spouse to take their pills, and a qualitative study has already confirmed that many participants saw PrEP as an opportunity to preserve their relationship despite the strain imposed by different HIV status.

He was asked why PrEP would be used in a couple where it would be more logical for the HIV-positive partner to be on treatment. He said one use of PrEP within couples might be to bridge the gap in time between the positive partner’s diagnosis and their starting treatment and becoming virally undetectable.

Van Damme said that the women in FEM-PrEP were much younger and had high levels of sexually transmitted infections (STIs). Initial qualitative surveys had shown that many did not believe themselves to be at high risk of HIV, despite high incidence in their community. There was also a high pregnancy rate in the study despite reported high levels of oral contraceptive use, showing that low adherence to medications was not restricted to Truvada. There was no evidence that participants were sharing their pills with others and, contrary to what the data initially suggested, the pregnancy rate was no higher in women taking PrEP, ruling out theories that interactions between the PrEP drugs and the menstrual cycle may have made women more vulnerable to HIV.

“What we have learned from this trial is that risk perception and understanding one’s own risk are important motivators for people to use biomedical prevention methods,” she concluded.

Dr Sharon Hillier of the Microbicides Trial Network, commenting on the PrEP trials at the conference, commented: “PrEP is very, very effective if you use it very, very well.”

References

Baeten J et al. ARV PrEP for HIV-1 prevention among heterosexual men and women. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, abstract 29, 2012. The abstract is available on the official conference website.

Van Damme L et al. The FEM-PrEP Trial of Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) among African Women. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, abstract 32LB, 2012. The abstract is available on the official conference website.

Donnell D et al. Tenofovir disoproxil fumarate drug levels indicate PrEP use is strongly correlated with HIV-1 protective effects: Kenya and Uganda. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, abstract 30, 2012. The abstract is available on the official conference website.

A webcast of the session HIV prevention: PrEP, microbicides and circumcision, is available through the official conference website.

Original Article via NAM

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

New Law in Los Angeles – Adult Movie Actor’s Required To Wear Condoms


Actors making pornographic movies in Los Angeles will be required to use condoms while filming, under a new law signed by the city mayor.

The new regulation has been welcomed by health officials but pornography industry leaders say it could force them to abandon the city.

LA’s San Fernando Valley is considered the capital of the multibillion-dollar US adult film industry.

Correspondents say it is not yet clear how the new law will be enforced.

The LA-based Aids Healthcare Foundation welcomed the move saying it was crucial in protecting adult film actors from HIV and other sexually transmitted diseases.

The foundation, which has campaigned for the measure for six years, said it would now seek similar condom requirement elsewhere in the US.

“The city of Los Angeles has done the right thing. They’ve done the right thing for the performers,” said foundation president Michael Weinstein.

He said his group would also be vigilant in keeping track of where porn producers might move to.

Several of the industry’s biggest adult filmmakers have said they might consider moving just outside city boundaries.

They insist that adult films featuring condoms are not as popular and that some actors prefer not to use them.

The new law was signed by Los Angeles Mayor Antonio Villaraigosa on Monday.

The city council has now asked the police, city attorney’s office and workplace safety officials to figure out how they enforce the rule, the Los Angeles Times reports.

Industry experts estimate as many as 90% of all pornographic films produced in the US are made in Los Angeles.

Last year, pornographic film productions across the US were temporarily shut down after an adult film performer tested positive for HIV – the virus that causes Aids.

Above article via BBC News

Our message is clear!

Condoms provide the best protection from HIV and other sexually transmitted infections.  HIV stands for human immunodeficiency virus. It was identified in the early 1980s and it belongs to a group of viruses called retroviruses.

Normally, the body’s immune system would fight off an infection, but HIV prevents the body’s immune system from working properly. HIV infects key cells in the body’s natural defences called CD4 cells, which co-ordinate the body’s response to infection. Many CD4 cells are destroyed by being infected, and some stop working as they should.

Although HIV can’t be cured, it can be treated. Modern HIV treatment means that many people with HIV are living long, healthy lives and can look forward to a near-normal lifespan.

AIDS
If HIV isn’t treated, the gradual weakening of the immune system leaves the body vulnerable to serious infections and cancers which it would normally be able to fight off. These are called ‘opportunistic infections’ because they take the opportunity of the body’s weakened immunity to take hold.

If someone with HIV develops certain opportunistic infections, they are diagnosed as having AIDS. The term ‘AIDS’ stands for acquired immune deficiency syndrome. People diagnosed as having AIDS can become unwell with a range of different illnesses, depending on the specific opportunistic infections they develop. This is why AIDS is not considered a disease, but a syndrome – a collection of different symptoms and illnesses, all caused by the same virus, HIV.

Most people who have HIV have not had an AIDS diagnosis. Also, if someone develops an AIDS-defining illness this doesn’t mean that they are on a one-way path to illness and death. Thanks to HIV treatment, many people who were once diagnosed as having AIDS are now living long and healthy lives.

Have you ever had a HIV test?

If you’re interested in having a HIV test, we offer a completely free and confidential rapid HIV test and you’ll get the results within 60 seconds from a simple finger prick test. We use the Insti HIV test produced by BioLytical laboratories. The test is 99.96% accurate from 90 days post contact for detecting HIV 1 and 2 antibodies. We also have a mobile testing van which is often out in communities providing mobile rapid HIV tests. Appointments are not always necessary, if you would like a test, please contact us on 0116 2559995

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

UK’s battle with HIV goes into reverse, prompting calls for more testing

The HIV 1 virus. The numbers infected with HIV within the UK are on the rise, the Health Protection Agency says. Photograph: Institut Pasteur/AFP/Getty Images

More than 100,000 people in Britain are predicted to be living with HIV by the end of this year, according to an official report that warns that the virus is on the rise again in the UK.

While there is a continuing drop in new cases among people who have acquired HIV abroad, the numbers infected within the UK are on the rise, the Health Protection Agency says in the report on Tuesday. New diagnoses of HIV in men who have sex with men have hit a record high.

New infections of the virus, which eventually causes Aids if not kept in check by drugs, had been falling in the UK but that trend seems to have levelled off, according to the agency’s annual HIV report. At the end of 2010, there were an estimated 91,500 people with HIV in the UK, up from 86,500 the previous year. The figure includes estimates for those who have not had a test and do not know they are infected – thought to be around a quarter of the total.

In 2010, according to the HPA’s data, there were 3,000 new infections among men who have sex with men, 81% of which occurred in the UK. Most of the men were white (83%) and two-thirds (67%) were born in the UK. Some had been HIV-positive for years without knowing, but a third of those who were recently infected were under 35. The figures suggest that one in 20 gay men are living with HIV, the ratio rising to one in 12 in London.

When the epidemic began 30 years ago, people with HIV swiftly became sick, developed Aids and died of infections such as pneumonia that their bodies could not fight off. Today, combinations of antiretroviral drugs keep people alive and healthy and can give them a normal lifespan as long as they stay on the medication. That means the number living with the virus continues to rise.

Of the 91,500 people estimated to have HIV in the UK, just over 40,000 of the total are men who have sex with men. Around 2,300 are injecting drug users. Of the 47,000 infected through heterosexual sex, around 19,300 were African-born women and 9,900 African-born men. The prevalence rate in the black African community is one in 32 among men and one in 15 women.

Half of those who are diagnosed with HIV have gone to a doctor years after infection, at the point when they have fallen ill. Those people have a much worse prognosis: they are 10 times more likely to die within a year of diagnosis than people who were diagnosed earlier.

In 2010, 680 HIV-positive people died, 510 of them men. Two-thirds were people who had been diagnosed late. Most died within a year of being tested.

People who have not been diagnosed risk infecting others. The HPA says that there is a need to introduce routine HIV tests around the country beyond the traditional confines of sexually transmitted infection and antenatal clinics.

There have been pilot projects in the last two years in London, Brighton, Leicester and Sheffield. Testing was successfully introduced in two general practices, the acute care units of three hospitals and two community settings without opposition from staff or patients.

Greater efforts to test people and prevent infection would save the NHS money, because treating people is expensive, the HPA says. Because HIV has become a chronic, manageable condition instead of a fatal illness, the costs of providing specialist treatment and care are substantial and accelerating.

“It is difficult to calculate the true expenditure on HIV in the UK. However, of the £1.9bn spent by the Department of Health on infectious diseases in England in 2009-10, an estimated 40% was allocated to the treatment of HIV and Aids. This total does not include the costs of psychosocial care or HIV testing, so in fact the total amount spent on HIV treatment is much higher,” the report says.

The amount spent on prevention, the HPA adds, was £2.9m, just 1% of the overall HIV budget in 2010. The report says: “Investing in prevention should be a priority because of its potential for cost savings. We estimate that each infection prevented would save between £280,000 and £360,000 in lifetime treatment costs.

“If the 3,640 UK-acquired HIV diagnoses made in 2010 had been prevented, between £1bn and £1.3bn lifetime treatment and clinical care costs would have been saved.”

Original Article by Sarah Boseley at The Guardian

STAY UPDATED
Follow LASS on Twitter
or subscribe via email